explore -WSS

explore

author：comprehensive 2025-10-01 22:59:39 - browse：7473

Two researchers look at a projection screen displaying medical devices, scientific graphs and DNA — health tech coverage from STAT — Adobe

The federal government’s plan to boost its oversight of the use of artificial intelligence tools in health care drew censure from startups arguing that overregulation stifles new ideas. But as Washington forges ahead, founders say they’re in the dark about who will be regulated and how — and they’re urging policymakers to offer clarity.

As they race for a slice of the $4 trillion U.S. health care market, AI founders and investors say regulatory uncertainty is a hurdle, forcing them to build more slowly and meticulously document for fear of potential audits. That makes it harder to keep up with the tech industry’s breakneck pace, they tell STAT.

The regulatory uncertainty adds to the many challenges dogging young health tech ventures today: Last year investments in digital health startups shriveled to their lowest annual total since 2019, and leaders are desperate to preserve what little funds they have, including through layoffs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： What nurses really want: sufficient staffing for patient care

hotspot

explore

WSS

Study: AI not yet building 'n

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Pharmacists can make shortage drugs, but at what cost?

Medicare says breakthrough device reimbursement rule to come by summer

Hospital price transparency does save money, advocate argues

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

focus

explore

knowledge

Malaria cases in Florida and Texas: Here’s what you need to know

Will Ozempic

The high cost of giving birth even with insurance

Apple Watch's A

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Senate committee scrutinizes Medicare Advantage brokers

Anesthesiologist group: stop taking Ozempic before surgery

Hospital price transparency does save money, advocate argues

Activists slam private health insurers over coverage restrictions

Researchers on aging grapple with how to calculate biological age

leisure time

Will Ozempic

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Beam Therapeutics to lay off 20% of its staff, re

Pharmacists can make shortage drugs, but at what cost?

Bird flu outbreak in cows is latest avian flu curveball

H5N1 communication has been strictly for the birds

hotspot

hotspot

explore

focus